POS1113 PROFILING OF SYSTEMIC IMMUNE RESPONSES IN AXIAL SPONDYLOARTHRITIS PATIENTS REVEALS STRIKINGL...
POS1113 PROFILING OF SYSTEMIC IMMUNE RESPONSES IN AXIAL SPONDYLOARTHRITIS PATIENTS REVEALS STRIKINGLY DISTINCT CELLULAR AND MOLECULAR MECHANISMS OF ACTION OF IL-17A INHIBITORS AND TNF-BLOCKERS
About this item
Full title
Author / Creator
Rosine, N. , Koturan, S. , Guillemot, V. , Leloup, C. , Veress, F. , Stephen, T. , Yahia, H. , Sellam, J. , Berenbaum, F. , Pietrosemoli, N. , Bianchi, E. , Miceli Richard, C. and Rogge, L.
Publisher
Kidlington: Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier B.V
Subjects
More information
Scope and Contents
Contents
IL-17A inhibitors (IL-17i) and TNF-inhibitors (TNFi) are currently the only biologic drugs available as first line treatment in axial spondyloarthritis (axSpA). While several studies have provided mechanistic insights into TNFi action, much less is known how IL-17i affect immune responses in patients.
We have compared the effects of IL-17i and T...
Alternative Titles
Full title
POS1113 PROFILING OF SYSTEMIC IMMUNE RESPONSES IN AXIAL SPONDYLOARTHRITIS PATIENTS REVEALS STRIKINGLY DISTINCT CELLULAR AND MOLECULAR MECHANISMS OF ACTION OF IL-17A INHIBITORS AND TNF-BLOCKERS
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2824802928
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2824802928
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2023-eular.5017
